临床药理学专家评审 SCIE

期刊简介预计审稿时间：

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

药物开发技术的进步正在催生创新的新疗法，从可能挽救生命的药物到生活方式产品。然而，近年来，开发新药的成本飙升，对耐药性和药物经济学的担忧也日益凸显。临床试验阶段的不良反应不断提醒人们严格的安全性和毒性测试的重要性。此外，药物基因组学和“个性化”治疗方法的出现将要求一种新的药物评估和医疗保健方法。

临床药理学在整合所有积极应对现代生物医学实践中此类挑战的专家和参与者的专业知识方面发挥着重要作用。

《Expert Review Of Clinical Pharmacology》(临床药理学专家评审)编辑部通讯方式为2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。